1. Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasms. Issue 11 (1st November 2020) Authors: Bar-Natan, Michal; Hoffman, Ronald Journal: Expert review of hematology Issue: Volume 13:Issue 11(2020) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunotherapy for multiple myeloma. Issue 1 (February 2014) Authors: Rosenblatt, Jacalyn; Bar-Natan, Michal; Munshi, Nikhil C; Avigan, David E Journal: Expert review of hematology Issue: Volume 7:Issue 1(2014) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunotherapy for multiple myeloma. Issue 1 (February 2014) Authors: Rosenblatt, Jacalyn; Bar-Natan, Michal; Munshi, Nikhil C; Avigan, David E Journal: Expert review of hematology Issue: Volume 7:Issue 1(2014) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia. (March 2020) Authors: Venugopal, Sangeetha; Bar-Natan, Michal; Mascarenhas, John O. Journal: Blood reviews Issue: Volume 40(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies. Issue 4 (9th April 2021) Authors: Feld, Jonathan; Tremblay, Douglas; Dougherty, Mikaela; Czaplinska, Tina; Sanchez, Gillian; Brady, Claudia; Kremyanskaya, Marina; Bar-Natan, Michal; Keyzner, Alla; Marcellino, Bridget K.; Gabrilove, Janice; Navada, Shyamala C.; Silverman, Lewis R.; El Jamal, Siraj M.; Mascarenhas, John; Shih, Alan H. Journal: HemaSphere Issue: Volume 5:Issue 4(2021) Page Start: e549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Issue 8 (August 2020) Authors: Zeidan, Amer M; Boddu, Prajwal C; Patnaik, Mrinal M; Bewersdorf, Jan Philipp; Stahl, Maximilian; Rampal, Raajit K; Shallis, Rory; Steensma, David P; Savona, Michael R; Sekeres, Mikkael A; Roboz, Gail J; DeAngelo, Daniel J; Schuh, Andre C; Padron, Eric; Zeidner, Joshua F; Walter, Roland B; Onida, ... Journal: Lancet Issue: Volume 7:Issue 8(2020) Page Start: e601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm. (November 2020) Authors: Tremblay, Douglas; Feld, Jonathan; Dougherty, Mikaela; Czaplinska, Tina; Sanchez, Gillian; Kremyanskaya, Marina; Bar-Natan, Michal; Shih, Alan H.; Keyzner, Alla; Mascarenhas, John Journal: Leukemia research Issue: Volume 98(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗